Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
Clinical trial NCT04868773 · COMPLETED
Trial details
- NCT number
- NCT04868773
- Sponsor
- University of California, Irvine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-16
- Primary completion
- 2023-08-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.